Showing results (71-80 of 389) with videos related to
Sort By:
Pageof 39
Oncology and Therapy|April 25, 2024
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case ExampleRonan Foley, John KuruvillaOncology and Therapy|October 18, 2023
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular LymphomaJavier Sanchez Alvarez, Mahmoud Jaber, Marie-Hélène Blanchet ZumofenOncology and Therapy|September 26, 2023
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and OncologistsStephen V Liu, Ivy B Elkins, Jill Feldman, et al.Oncology and Therapy|September 21, 2024
A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United StatesRobert Ristuccia, Yang Zhao, Chunlan Chang, et al.Oncology and Therapy|March 2, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing ApproachMohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.Oncology and Therapy|February 19, 2026
Time and Resource Implications of Subcutaneous Daratumumab-Based versus Intravenous Isatuximab-Based Treatment Regimens for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant IneligibleEmma Smith, Alessandro Camera, Alex BirdOncology and Therapy|February 23, 2026
Several Considerations on the Pathology, Treatment, and Prognosis of Laryngeal NUT CarcinomaAndrés Coca-Pelaz, Alfio FerlitoOncology and Therapy|November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation ProfilerFrancesco Pepe, Gianluca Russo, Nadia Barraco, et al.Oncology and Therapy|May 22, 2026
Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic VulnerabilitiesMoslem Javidan, Zahra Jafari, Shahdokht Abbasiniya, et al.Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.Pageof 39